Back to search

Article

KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson’s disease

2020-07-07

Abstract excerpt

<h4>Background and Purpose</h4> Monoamine oxidase-B (MAO-B) is a long-standing therapeutic target for Parkinson’s disease (PD), however, previous clinical studies demonstrated discouraging effects of currently available irreversible MAO-B inhibitors. Since KDS2010, a novel, potent, selective, and reversible MAO-B inhibitor, has been developed, here we tested its therapeutic potential in animal models of PD. <h4>E...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dff67ac8-6386-51c2-b50d-b561c89d8246
DOI
10.1101/2020.07.06.190579
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson’s diseaseDOI 10.1101/2020.07.06.190579
Select a neighboring publication to make it the new centre.